(Q45886686)

17 December 2017

title

Antitumoral efficacy of DNA nanoparticles in murine models of lung cancer and pulmonary metastasis (English)

1 reference

17 December 2017

0 references

4

1 reference

17 December 2017

author name string

M Rodrigo-Garzón

1

1 reference

17 December 2017

P Berraondo

2

1 reference

17 December 2017

L Ochoa

3

1 reference

17 December 2017

G González-Aseguinolaza

5

1 reference

17 December 2017

publication date

1 January 2010

1 reference

17 December 2017

published in

Cancer Gene Therapy

1 reference

17 December 2017

volume

17

1 reference

17 December 2017

page(s)

20-27

1 reference

17 December 2017

issue

1

1 reference

17 December 2017

https://scigraph.springernature.com/pub.10.1038/cgt.2009.45

exact match

0 references

cites work

Update in lung cancer 2007

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.45

Cancer burden in the year 2000. The global picture

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.45

Interleukin-12 and the regulation of innate resistance and adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.45

Antitumor and antimetastatic activity of interleukin 12 against murine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.45

Antitumor efficacy of adenocarcinoma cells engineered to produce interleukin 12 (IL-12) or other cytokines compared with exogenous IL-12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.45

IL-12 treatment of endogenously arising murine brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.45

Phase II study of intraperitoneal recombinant interleukin-12 (rhIL-12) in patients with peritoneal carcinomatosis (residual disease < 1 cm) associated with ovarian cancer or primary peritoneal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.45

Gene therapy for lung cancer and mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.45

Gene therapy for lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.45

Intranasal interleukin-12 gene therapy enhanced the activity of ifosfamide against osteosarcoma lung metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.45

Gene therapy of cancer based on interleukin 12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.45

A phase I clinical trial of single-dose intrapleural IFN-beta gene transfer for malignant pleural mesothelioma and metastatic pleural effusions: high rate of antitumor immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.45

The influence of polymer structure on the interactions of cationic polymers with DNA and morphology of the resulting complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.45

Size, diffusibility and transfection performance of linear PEI/DNA complexes in the mouse central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.45

In vivo delivery to tumors of DNA complexed with linear polyethylenimine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.45

Ovarian carcinoma cells are effectively transfected by polyethylenimine (PEI) derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.45

ExGen 500 is an efficient vector for gene delivery to lung epithelial cells in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.45

ELISPOT assay to measure antigen-specific murine CD8(+) T cell responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.45

Intrahepatic injection of recombinant adeno-associated virus serotype 2 overcomes gender-related differences in liver transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.45

Toll-like receptor 9-dependent immune activation by unmethylated CpG motifs in Aspergillus fumigatus DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.45

Sequential activation of NKT cells and NK cells provides effective innate immunotherapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.45

Direct immunologic activities of CpG DNA and implications for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.45

Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.45

Promoter attenuation in gene therapy: interferon-gamma and tumor necrosis factor-alpha inhibit transgene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.45

Intravenous cytokine gene delivery by lipid-DNA complexes controls the growth of established lung metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.45

Systemic administration of LPD prepared with CpG oligonucleotides inhibits the growth of established pulmonary metastases by stimulating innate and acquired antitumor immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.45

LPD lipopolyplex initiates a potent cytokine response and inhibits tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.45

Induction of gp120-specific protective immune responses by genetic vaccination with linear polyethylenimine-plasmid complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.45

Improving efficacy of interleukin-12-transfected dendritic cells injected into murine colon cancer with anti-CD137 monoclonal antibodies and alloantigens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.45

Randomized phase II study of interleukin-12 in combination with rituximab in previously treated non-Hodgkin's lymphoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.45

7 January 2021

Immune modulation as a therapeutic strategy for non-small-cell lung cancer.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.45

7 January 2021

p53 aerosol formulation with low toxicity and high efficiency for early lung cancer treatment

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.45

7 January 2021

Bacterial DNA-induced NK cell IFN-gamma production is dependent on macrophage secretion of IL-12

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.45

7 January 2021

Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.45

7 January 2021

The inhibitory role of CpG immunostimulatory motifs in cationic lipid vector-mediated transgene expression in vivo

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.45

7 January 2021

Identifiers

DOI

10.1038/CGT.2009.45

1 reference

17 December 2017

Dimensions Publication ID

0 references

1 reference

17 December 2017